EUVIMEDEUVIMED entdecken
Crossref

Association of vascular endothelial growth factor‐C, plasma angiotensinogen and left ventricular hypertrophy in patients with hemodialysis

Haci Hasan Yeter iD, Mustafa Levent iD, Levent Sahiner, Tolga Yildirim, Rahmi Yilmaz

Therapeutic Apheresis and Dialysis · 2024

DOI: 10.1111/1744-9987.14178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2024. Verfasst von Haci Hasan Yeter und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: Hypertrophy, Left Ventricular, Renal Dialysis, Angiotensinogen, Vascular Endothelial Growth Factor C. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study aims to examine the relationship between fluid overload, Vascular Endothelial Growth Factor C (VEGF‐C), plasma Angiotensinogen (pAGT), and echocardiography findings in hemodialysis patients.

Methods

This was a single‐center, cross‐sectional study. Patients were divided into two groups according to mid‐week inter‐dialytic weight gain (mIDWG): (1) mIDWG ≤3% and (2) mIDW >3%.

Results

A total of 55 patients were enrolled in this study. While the mean pAGT and left ventricular mass index were significantly higher in patients with mIDWG >3% compared to patients with mIDWG ≤3%, VEGF‐C was similar between groups. pAGT ≥76.8 mcg/L, VEGF‐C ≤175.5 pg/ML, and pAGT /VEGF‐C ≥0.45 were significant cut‐offs for the prediction of left ventricular hypertrophy(LVH). Univariate logistic regression analysis revealed that these cut‐off values were significantly associated with LVH.

Conclusion

Renin‐angiotensin‐aldosterone system activation may persist in hemodialysis patients with excessive IDWG. Additionally, pAGT and VEGF‐C could be risk factors for the development of LVH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertrophy, Left VentricularRenal DialysisAngiotensinogenVascular Endothelial Growth Factor CEchocardiographyHumansMaleFemaleCross-Sectional StudiesMiddle AgedRenin-Angiotensin SystemAgedWeight GainKidney Failure, ChronicBiomarkers

Stichwörter der Autor:innen

angiotensinogenhemodialysisleft ventricular hypertrophyvascular endothelial growth factor C

Substanzen

AngiotensinogenVascular Endothelial Growth Factor CBiomarkers

Autor:innen und Institutionen

  • Department of Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Department of Geriatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

ORCID-Profile: Haci Hasan Yeter, Mustafa Levent

Zitieren

APA

Yeter, H. H., Levent, M., Sahiner, L., Yildirim, T., & Yilmaz, R. (2024). Association of vascular endothelial growth factor‐C, plasma angiotensinogen and left ventricular hypertrophy in patients with hemodialysis. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14178

Vancouver

Yeter HH, Levent M, Sahiner L, Yildirim T, Yilmaz R. Association of vascular endothelial growth factor‐C, plasma angiotensinogen and left ventricular hypertrophy in patients with hemodialysis. Therapeutic Apheresis and Dialysis. 2024. doi:10.1111/1744-9987.14178

BibTeX
@article{Yeter2024,
  author = {Yeter, Haci Hasan and Levent, Mustafa and Sahiner, Levent and Yildirim, Tolga and Yilmaz, Rahmi},
  title = {Association of vascular endothelial growth factor‐C, plasma angiotensinogen and left ventricular hypertrophy in patients with hemodialysis},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2024},
  doi = {10.1111/1744-9987.14178}
}
Kostenlos starten →